Frontlight ResearchEarly access
Ovarian cancer trials, also abroad
803 open Ovarian cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| United States | 351 |
| China | 185 |
| Italy | 101 |
| France | 99 |
| Spain | 90 |
| All other countries |
The same trial often runs in several countries
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer has 9 sites in India and runs in 29 countries. If a site near you is full, another one may still take people.
See Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer in all 29 countries